Hs Info

MPS II (Hunter syndrome) is one of 7 clinical types of mucopolysaccharidoses (MPS) diseases: a group of rare, genetic, metabolic disorders. In this episode, Dr Lampe (Centre for Rare Diseases, Geissen University Hospital, Germany), discusses the practicalities of achieving an earlier MPS II diagnosis – a crucial challenge towards improved disease management. Dr Lampe shares 12 years of experience in the field of MPS, covering exactly how MPS II impacts the quality of life of patients and their families. Ultimately, Dr Lampe explains the combination of symptoms that can prompt an earlier suspicion of MPS II, and how this can unlock appropriate disease management and patient support. This podcast series was initiated, organised and funded by Takeda and is intended for a global healthcare professional audience (excluding US and the UK).